Clinical Trials Browser

Interventional × Erlotinib Hydrochloride × Other hematologic neoplasm × Clear all

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT01174043 2023-10-13

Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

Phase 2 Completed

11 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Myelomonocytic, Acute

NCT00977548 2013-09-16

Erlotinib Study for Myelodysplastic Syndrome (MDS)

Phase 2 Completed

39 enrolled 10 charts

MyeloidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Myelodysplastic Syndromes

Clinical Trials

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

Erlotinib Study for Myelodysplastic Syndrome (MDS)